Ads
related to: pathophysiology of breast cancer
Search results
Results from the WOW.Com Content Network
Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. [ 17 ] In 2018, it resulted in two million new cases and 627,000 deaths. [ 18 ] It is more common in developed countries, [ 2 ] and is more than 100 times more common in women than in men.
Invasive carcinoma NST is a type of breast cancer. It is one of the invasive breast cancers that originates from the breast ductal system, so that it is a type of ductal carcinoma. A defining feature of this ductal carcinoma is that it lacks the "specific differentiating features" of other types of ductal carcinomas.
James Paget. Paget's disease of the breast (also known as mammary Paget's disease) is a rare skin change at the nipple nearly always associated with underlying breast cancer. [2] Paget's disease of the breast was first described by Sir James Paget in 1874. [3] The condition is an uncommon disease accounting for 1 to 4% of all breast cancers cases.
Metastatic breast cancer to the lung or pleura causes chronic cough, dyspnea, abnormal chest X-ray, and chest pain. Other nonspecific systemic symptoms of metastatic breast cancer include fatigue, malaise, weight loss, and poor appetite. Sometimes people with metastatic breast cancer do not have any notable changes or symptoms. [8]
Age is the biggest risk factor for breast cancer. The risk of getting breast cancer increases with age. A woman is more than 100 times more likely to develop breast cancer in her 60s than in her 20s. [4] The risk over a woman's lifetime is, according to one 2021 review, approximately "1.5% risk at age 40, 3% at age 50, and more than 4% at age 70."
Inflammatory breast cancer is a high-grade aneuploid cancer, with mutations and overexpression of p53, [13] high levels of E-cadherin and abnormal cadherin function. It is often regarded as a systemic cancer. A large number of IBC cases present as triple negative breast cancer (TNBC).
Stage 0 is a pre-cancerous or marker condition, either ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Stages 1–3 are within the breast or regional lymph nodes. Stage 4 is a metastatic cancer. Metastatic breast cancer has a less favorable prognosis. Receptor status.
Triple-negative breast cancer comprises 15–20% of all breast cancer cases [3] and affects more young women or women with a mutation in the BRCA1 gene than other breast cancers. [4] Triple-negative breast cancers comprise a very heterogeneous group of cancers. TNBC is the most challenging breast cancer type to treat. [5]
Ads
related to: pathophysiology of breast cancer